Modified Citrus Pectin Market to Reach $620 Million by 2027: Data-Driven Growth Analysis The Modified Citrus Pectin market has experienced steady expansion, reaching USD 380 million in 2020 and projected to achieve USD 620 million by 2027, reflecting a CAGR of 7.3%. Increasing demand in nutraceuticals, oncology support supplements, and functional foods is driving growth. North America dominated with 39% market share in 2020, followed by Europe at 31% and APAC at 22%. Read Full Research Study: Modified Citrus Pectin https://marketintelo.com/report/modified-citrus-pectin-market

Top 7 Innovations in HA-Based Nutraceuticals According to a newly published market research report by 24LifeSciences, global health food hyaluronic acid market was valued at USD 1.15 billion in 2024 and is projected to reach USD 2.45 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period 2025-2032. Health Food Hyaluronic Acid, a high-purity glycosaminoglycan, is increasingly incorporated into nutraceuticals and dietary supplements for its dual benefits in enhancing skin hydration and supporting joint health. Unlike topical applications, these ingestible products are designed to deliver systemic benefits from within, primarily by improving synovial fluid viscosity which helps relieve osteoarthritis symptoms. Its growing prominence is underpinned by extensive clinical research validating its efficacy and safety for oral consumption. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12388/health-food-hyaluronic-acid-market

Gleason Healthcare is a rapidly growing Indian pharmaceutical company established in 2012 and headquartered in Surat, Gujarat. Specializing in the manufacturing and marketing of generic drugs, hormone preparations, and nutraceuticals, Gleason Healthcare is committed to delivering affordable and innovative medications. With a focus on quality, innovation, and customer satisfaction, the company has adopted a technology-driven approach to succeed in the emerging market. Gleason Healthcare's core strengths and competitive edge rely on its established presence in diverse therapeutic areas, including oncology, hepatology, HIV, and gastroenterology. With R&D facilities and manufacturing centers located across India, the company has already established a strong global presence. At Gleason Healthcare, the mission is to make a difference in people's lives by delivering innovative, lifesaving drugs. https://gleasonhealthcare.com/